Background Diabetes is a metabolic disorder that is characterized by chronic high blood glucose levels that causes complications in the eyes, kidneys, heart, vessels and nerves. Currently diabetic nephropathy is the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes. Honey bee venom can be considered as a natural remedy for diabetes due to its blood glucose levels lowering and lipid-regulating effect on diabetic rabbits. Aim The aim of this study was to investigate the effect of Mongolian honey bee venom (Apis mellifera) on renal dysfunction in alloxan induced diabetic rabbits. Material and Method Twenty two Chinchilla rabbits were divided into three groups: control (n=6), diabetic (n=8), and bee venom treated (n=8). The diabetic group was injected with 5% solution of Alloxan monohydrate 100 mg/kg intravenously behind the ear for 2 minutes to induce diabetes. The bee venom treated group received a bee sting (a sting contains 0.2-0.5 ml of bee venom) on their hind paw every day after their diagnosis of diabetes. Result Bee venom treatment (BVT) led to the following changes: compared to the diabetic group, the bee venom treated group’s blood glucose levels lowered between 14.9% and 26.5%; the plasma creatinine and urea levels were decreased respectively by 19,8% and 14.8%. Blood urea nitrogen (BUN) levels were reduced by 14.8%. Conclusion: Treatment with Mongolian bee venom lowered the blood glucose levels and prevents the renal dysfunction in alloxan induced diabetic rabbits

Introduction In 19th century, researchers proved at biochemical level the healing properties of bee products such as bee venom, honey, royal jelly, pollen, propolis and wax. The object of our research is the Apis cerena’s venom properties1-2. Asiatic honey bee or Apis cerana is small honey are small honey bees of southern and southeastern Asia, such as China, India, Japan, Malaysia, Nepal, Bangladesh and Papua New Guinea3. This species is also known as the Himalayan hive honeybee. This species is the sister species of Apis koschevnikovi, and both are in the same sub¬genus as the Western (European) honey bee, Apis mellifera4. Goal The purpose of our research is to study property and potential of bee venom and its effect on immune system. Heal¬ing property of Apis cerana was high. This study proves that bee venom therapy stimulates immunity. Materialis and Methods The research was conducted at the Scientific Research Center of “Monos” Institute of Traditional Medicine and in biochemical Laboratory of “Khuljborjigon” Clinic. For the experiment, we used 23 perfectly healthy mice of same sex and size which meets standards of laboratory testing. We put a bee sting to 0.5 ml of 10% red blood cell (RBC) solution and measured time of heamolysis to de¬fine bee venom potential/capability by Shkenderov S., Ivanov Ts., (1985) method. Following Erne (1963), Kovalev I.E.,(1976), Petrov’s (1980) methodology of studying effects on immune system, we have stung bee venom to 23 mice on the acupuncture point of hind paw every other day in total 3 times. On third day of the experiment, we in¬jected into vein 2ml of 10 % sheep’s RBC to stimulate the immunity. On the fifth day, we defined weight of pancreas, number of pancreatic cells, pancreatic index, and haemagglutination titre. Results Potential of bee venom is determined by speed of heamolysis when bee sting is placed in the 0.5 ml of 10% RBC solution. If we place one bee sting into 1ml of RBC solution then the speed of heamolysis is 46 seconds, when two stings are place speed is 38 seconds and when 3 stings placed then time is 30. Compare to usual speed of heamolysis which is 60 seconds, change in time depending on the number of bee stings proves the effectiveness of bee venom (Table 1). In figure 3, the number of spleen cells of control group’s was 142.71±55.51*106/ml. this is 1.2 times lower compare to normal group which is 172.67±135.5*106/ml. BVT group’s number of spleen cells was 329.78±187.78*106/ml and 1.61 times bigger than in control group. In comparison to control group, haemagglutina¬tion titre of BVT group was 1.13 times higher (BVT group 54.86±19.95%; control group 50±8.83%, p<0.05) and this indicates that BV has immunity stimulating effect. Conclusions From our experiment we can conclude the following 1. Apis mellifera’s bee venom has high treating effect. 2. Bee venom therapy has immunity stimulating activity.

The biologically active food supplement products were produced in the form natural raw materials for powder, tablets, pellets, capsule, juice and extract preparation. Osteoporosis disease is increasing among the population of the world in recent years. Therefore, calcium supplement is used more often for prevention of this disease. Osteoporosis is now widely recognized as a public health problem since this disease, which increases bone fragility and thereby the risk of fractures, is associated with high mortality, morbidity and medical expenses throughout the world. We obtained new “Eghomon” supplement which reduces osteoporosis. We determined by quantitative analysis, the calcium ion and mineral composition is a crystal structure in this supplement. In the study, we used titrimetric, X-ray fl uorescence and X-ray diffractometer spectroscopy methods. The following mineral elements such as, Ca, P, Mg, Fe, Mn, Al, Na, K, Si, Ti were contained in the Eghomon supplement. Additionally, we determined the concentration of calcium ion 22.9 percent in the supplement. INTRODUCTION Mineral ions such as calcium, phosphorus, magnesium, copper, zinc, etc.., play a tremendous role in the metabolic processes of the human body, including tissue, fl uid, and bone. In each are they function to promote and maintain normal body function with a wide range of activities including assisting in body hydration, enzyme activation, maintenance of pH, as cofactors in blood coagulation, controlling neuromuscular excitability, as well as promoting the stability of bones and teeth, and many other functions. Calcium is the most abundant mineral in the human body, most of which (98%) is present in the skeleton. The concentration of calcium ion in the blood is very important for the development and preservation of strong bones and teeth. Absorption of too much calcium in the blood may lead to the leaching of calcium from the bones and teeth. The absorption of calcium is controlled, in part, by vitamin D. Growing children in particular need an ample supply of calcium for the development of strong bones. Milk, which is a good natural source of calcium and which is consumed primarily by children, is usually fortifi ed with vitamin D to promote calcium absorption. Similarly, outdoor recess for elementary school children is mandated by law in many states because exposure to sunshine allows the body to synthesize vitamin D. In later adulthood, particularly among women, the level of calcium in the blood may decrease to the point where calcium is removed from the bones and teeth to replace the blood calcium, making the bones and teeth much weaker and more susceptible to fracture. This condition is known as osteoporosis and can become very serious, causing shrinking if the skeleton and severe arthritis. For this reason, calcium supplements are often prescribed in an effort to maintain the proper concentration of calciumion in the blood. Although the results are not yet conclusive, recent reports indicate 100mg of calcium ion, taken orally on a daily basis, may serve to prevent osteoporosis. Typically, such calcium supplements consist of calcium carbonate, calcium citrate and calcium lactate. MATERIALS AND METHODS We conducted used in the study of natural biologically active food supplements Eghomon. The researchers invented new Eghomon supplement in the institute of traditional medicine and technology of Mongolia. Eghomon is composed from horse bones and eggshells. It is a calcium preparation.

Background: Wound healing mechanisms still unclear. Wounds are physical injuries that result in an opening or breaking of the skin. Proper healing of wounds is essential for the restoration of disrupted anatomical continuity and disturbed functional status of the skin. This is a product of the integrated response of several cell types to injury. Wound healing is a complex process that results in the contraction and closure of the wound and restoration of a functional barrier.Goal: The purpose of this study was to determine burn wound healing activity of Calvacin. Materials and Methods:We used in study as colored reaction thin layer chromatography (TLC) and UV-spectrophotometer methods to determine active compounds in the three component drug "Calvacin".In research were inducted 20 healthy white mice and 40 rats. Investigation was based and implemented at scientific research laboratory of Traditional Medical Science Technology and Production Corporation and Institute of Veterinary medicine of pathological laboratory. The study protocol was approved by the Ethics Committee of the Ministry of Health.Results:Results of the phytochemical investigations showed that contained in the new drug "Calvacin" determined the presence of bioactive substances such as flavonoids, saponin, tannin, curcuminoids, organic acids and minerals. Substance was absorbed 25.7% in 40 grade ethanol, 27.1% in 70 grade, 22.2% in 96 grade and 19.6% in sterile water. We was established quality quantities of Calvacin in the drug amount summary flavonoids 1% and determined by UV spectrophotometer method. Proceeding from the absorption maximum of the substances analyzed the wave length of detection was determined as 370nm. In the result of mineral study of the "Calvacin", Ca^2.3%, P-6.17%, K-5.58%Burn wound healing time is control group 35±0.1 days, on 26±0.1 day animals of Calvacin group, but animals of Vishinski's ointment group 33±0.1 (p<0.05).Conclusions:1. The phytochemical investigations contained in the "Calvacin" drug determined the presence of bioactive substances such as flavonoids, saponin, tannin, curcuminoids, organic acids and minerals.2. Calvacin preparation has less toxic and significantly stimulate experimentally induced wound contract.

BackgroundThese study made us to investigate the drug row material of Mongolian traditional medicine such us Tribulus terrestris, Malva neclecta Wall and Eriocheir sinensis compounded preparation named “Malbus”. Investigated us preparations steel using for treatment of kidney and urinetract deseases, it is one of effective in Mongolian traditional drug preparations.Material and MethodsThe experimental protocol was approved by the Ethics Review Committee at the Ministry Health of Mongolia. In research we used 20 healthy mice and 60 Wistar rats. Investigation was based and implemented at scientific research laboratory of Traditional Medical Science Technology and Producttion Corporation and pathological laboratory of Institute Veterinary medicine. Chemically acting substances is steroid saponin content in Malbus compound was detected by using thin layerchromatography (TLC) and its value was determined by UV-spectrophotometry. The acute oral toxicity study was according to the method Prozorovsky (1978). The toxic nephrosis was produced using Gentamicin (80 mg/kg) rats by using Neugarten’s method (1983).ResultsThe ethanolic extract results of the phytochemical investigations showed that conteined in the “Malbus” determined the presence of bioactive substances such as flavonoids, steroid saponins. The ethanolic extract of Malbus was found to be LD50 of 16.3 g/kg. Toxic nephrosis was induced in Wistar rats administered preparation Malbus dose 80 mg/kg, 160 mg/kg, and 240 mg/kg. Blood levels of creatinine, uric acid, and urea were siginificantly reduced by Malbus treatment compared tocontrol. Histological study revealed that Malbus was effective for treatment of nephritis in rats induced by gentamicin.Conclusions:1. The ethanolic extract of “Malbus” compound determined the presence of bioactive substances such as flavonoids, steroid saponins.2. LD50 of Malbus 16.3 g/kg, the preparation is has nephroprotective effect on experimental Gentamicine induced nephrosis in rats.

Introduction: In 19thcentury, researchers proved at biochemical level the healing properties of bee products such as bee venom, honey,royal jelly, pollen, propolis and wax. The object of our research is the Apis cerena’s venom properties1-2. Asiatic honey bee orApis ceranais small honey are small honey bees of southern andsoutheastern Asia, such as China, India, Japan, Malaysia, Nepal, Bangladesh and Papua New Guinea3. This species is also known as the Himalayan hivehoneybee. This species is the sister species of Apis koschevnikovi, and both are in the same subgenus as the Western (European) honey bee, Apis mellifera4.

Introduction Medicinal plants and herbal drug Introduction Medicinal plants and herbal drugs have made and a tremendous contribution to national health and development from the very beginning. Fora very long time, people have used locally available medicinal plants for medicaltreatment and have eaten certain vegetables and spices for health protection as well as sustenance. Even though in traditional medicine, we use many different medicinal plants and herbal preparations for treatment of various diseases, most of them are not completely studied yet. One of these herbal preparations is Jonsh-6. The research group reported already that the preparation Jonsh-6 has pharmacological effects such as to treat diseases such as gastritis, stomach disorder (B.Uyanga, S.Seesregdorj, 2011) and at this time there aren’t any other studies made in respect to the preparation Jonsh-6. The aim of our research is to complete qualitical and quantitative analyses of biological active substance in the preparation Jonsh-6. Material and methods The contents of the preparation Jonsh-6 are Calcitum-0.3g, Piper longim L- 0.08g, Aucklanda lappa Decne-0,15g, Inula helenium L-0.15g, Carthamus tinctorius L-0.24g, Amomum Kravanh Pierreex Gagnep-0.08g.Analyses of the preparation were studied by using HPLC on Waters Delta 600 Pump, Waters 600 Controller, Waters 2487 DualχAbsorbance Detector, Pinnacle II C18 5μm, 250x4.6 ммand selected following conditions: mobile phase: Acetonitrile:water/50:50,Acetonitrile:0.7% phosphoric acid /25:75,wavelength 210, 338, 403 nm, Detector: UVvis, column: Pinnacle IIC18 5μm (250x4.6 мм), flow rate 1.0 ml/min. Key words: HPLC, Jonsh-6, Safflomin-A, Piperine, Alantolaktone, and Costunolide. Conclusion In order to succeed the above mentioned aim, we have achieved the following results: 3. The chromatographical method and methodology forthe qualitical and quantitative analyses of main compounds in the preparation Jonsh-6 were developed using HPLC. 4. The quantity of main components in the preparation Jonsh-6 were determined with HPLC and Safflomin-A 1.06 mg, piperine 0.195 mg, alantolaktone 1.12 mg and costunolide 0.925 mg are contained in 1.003 gm of the preparation.

In last years we have produced a combination species from medicinal plants which are used in traditional medicine and has tendentious the increasing of needs and production of plant preparations from natural resources. Although traditional medicine has being increased to be used last years, standardization of them is not sufficient. The standardization is important to ensure the safety, effectiveness and quality of traditional medicine. This research was made with purposes for determining of qualitative and quantitative analyses of biological active substances in the preparation such as Jonsh-5 is utilized to prevent osteoporosis, to accelerate bone ankylose in period of injure. The compositions of the preparation Jonsh-5 are Calcitum, Carduus crispus L. Inula helenium L.Terminalia chebula Retz, Forsutima suspense Thunb. Vahl.In order to succeed the above mentioned aim, we have achieved the following results: 1. The chromatographical method and methodology for the qualitative and quantitative analyses of main compounds in the preparation Jonsh-5 were developed using HPLC. 2. Quantitative analyses of main compounds of the compositions in the preparations were defined by HPLC method. 1.000gr of the preparation Jonsh-5 involves gallic acid 1.11 mg, alantolaktone 1.77 mg.

Introduction: Diabetes mellitus is a complex, progressive disease, which is accompanied by multiple cardiovascular complications. Oxidative stress is significantly increased in diabetic patients and may lead to great haemostatic disturbances existing in these patients. The major thrust was to review current literature on potential interrelationships between haemostatic and metabolic abnormalities in diabetes mellitus. Zomoshin-6 decoction and Caragana jubata (Fabaceace) used in traditional Mongolian medicine have been shown to have haemostatic and antiviral effects. Objectives: The aim of this study was to examine the effect of Caragana jubata (Pall.) Poir. and Zomoshin-6 decoction on haemostatic parameters and lipid profiles in diabetic rats. Methods: Diabetes was induced in rats by using alloxan at a dose of 150 mg/kg. Control group received distilled water. Caragana jubata (Pall.) Poir and Zomoshin-6 were administered orally at doses of 2.0 g/kg and 0.2 g/kg respectively. Aspirin (100mg/kg) was used for comparison as a standard medicine. All treatments were performed daily for 3 weeks. Blood samples were obtained and analyzed for fibrinogen levels, prothrombin time, triglycerides (TG) and plasma uric acid. Results and conclusions: Levels of TG (p<0.05), glucose (p<0.03) and plasma uric acid (p<0.02) were increased in rats administered alloxan compare to control and these were significantly reduced by Caragana jubata and Zomoshin-6 treatments (Table 1). Caragana jubata and Zomoshin-6 significantly reduced increases in fibrinogen (p<0.05) level and prothrombin time induced by alloxan (Table 2). Table 1. Effect of Caragana jubata (Pall.) Poir and Zomoshin-6 on alloxan-induced increase in levels in TG, uric acid, and glucose. Table 2. Effect of Caragana jubata (Pall.) Poir and Zomoshin-6 on levels of fibrinogen and prothrombin time in rats given alloxan Parameters Control Alloxan 150 mg/kg Alloxan 150 mg/kg Caragana jubata 2.0 g/kg Zomoshin-6 tan 0.2 g/kg Aspirin 100 mg/kg Triglycerde ( mg/dl) 80.9±2.9 139.1±1.7 57±1.8* 64.0±2.5* 75±1.7* Uric acid (mg/dl)1.3±0.4 2.82±0.9 0.85±0.1* 0.9±0.2** 1.1±0.6* Glucose (mg/dl) 110.3±2.8 140±11 99.2±5*** 135.5±22* 125.2±31* Control Alloxan 150 mg/kg Alloxan 150 mg/kg Caragana jubata 2.0 g/kg Zomoshin-6 0.2 g/kg Aspirin 100 mg/kg Fibrinogen (g/l)221.2±8.7 254±3.7 264.3±4.0* 207.4±3.5** 168.4±1.9** Prothrombin time (sec) 14.1±4.6 9.57±0.3* 22.7±2.3* 22.8±0.7** 20.5±3